isf 2405 has been researched along with mocetinostat in 1 studies
Studies (isf 2405) | Trials (isf 2405) | Recent Studies (post-2010) (isf 2405) | Studies (mocetinostat) | Trials (mocetinostat) | Recent Studies (post-2010) (mocetinostat) |
---|---|---|---|---|---|
9 | 1 | 0 | 21,735 | 390 | 8,606 |
Protein | Taxonomy | isf 2405 (IC50) | mocetinostat (IC50) |
---|---|---|---|
Histone deacetylase 3 | Homo sapiens (human) | 0.7851 | |
Nuclear receptor corepressor 1 | Homo sapiens (human) | 0.022 | |
Cytochrome P450 3A4 | Homo sapiens (human) | 0.57 | |
Cytochrome P450 2D6 | Homo sapiens (human) | 0.102 | |
Cytochrome P450 2C19 | Homo sapiens (human) | 0.102 | |
Histone deacetylase 4 | Homo sapiens (human) | 0.5717 | |
Histone deacetylase 1 | Homo sapiens (human) | 0.3433 | |
Histone deacetylase 7 | Homo sapiens (human) | 0.6725 | |
Histone deacetylase 2 | Homo sapiens (human) | 0.3537 | |
Histone deacetylase 11 | Homo sapiens (human) | 0.6386 | |
Histone deacetylase 8 | Homo sapiens (human) | 0.6725 | |
Histone deacetylase 6 | Homo sapiens (human) | 0.5717 | |
Histone deacetylase 5 | Homo sapiens (human) | 0.6725 | |
Nuclear receptor corepressor 2 | Homo sapiens (human) | 0.045 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nässberger, L | 1 |
1 other study(ies) available for isf 2405 and mocetinostat
Article | Year |
---|---|
The antihypertensive compounds hydralazine, dihydralazine and cadralazine and their metabolites inhibit myeloperoxidase activity as measured by chemiluminescence.
Topics: Antihypertensive Agents; Binding Sites; Dihydralazine; Dose-Response Relationship, Drug; Hydralazine; Luminescent Measurements; Magnetic Resonance Spectroscopy; Peroxidase; Pyridazines; Structure-Activity Relationship | 1991 |